The number of U.S. individuals on long-term opioid therapy fell from 5.6 million in 2015 to 4.2 million in 2023. Co-prescribing opioids with gabapentinoids increased, however, reaching 58.7% in 2023.

Last week, researchers dropped a bombshell report on DFNZ, a developing new medicine derived from a class of drugs once considered too dangerous to even study. Their proposal sounded almost too good ...

Long-term opioid prescribing has fallen in the United States over the last decade, but millions of patients still received opioids for 90 days or longer in 2023, according to a new research letter in ...

For decades, the opioid crisis has devastated communities across the United States. More than 700,000 Americans have lost their lives to overdoses since the epidemic began, leaving families shattered ...

Albertsons swung to a fourth-quarter loss fueled by a charge from a new opioid settlement set to resolve substantially all opioid-related claims brought against the company. The company reported a ...

Long-term opioid therapy fell 24.3% from 2015 to 2023, but utilization remained high, totaling 4.2 million active patients and over 16.3 million episodes across the study period. Patient mix shifted ...

Sam Quinones, a journalist, is the author of five books, including “Dreamland: The True Tale of America’s Opiate Epidemic” and “The Least of Us: True Tales of America and Hope in the Time of Fentanyl ...

(FOX40.COM) — One of the nation’s largest supermarket chains will pay hundreds of millions of dollars to settle claims related to the opioid epidemic. California Attorney General Rob Bonta announced ...

BOSTON (AP) — McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly ...

A designer drug described as 10 times more potent than fentanyl is causing an uptick in U.S. overdoses, according to health officials in multiple states. Known as cychlorphine, the synthetic opioid is ...

Recent advances in pain science, including the development of sodium channel-inhibiting drugs and a more thorough understanding of nociplastic pain, are expanding the landscape of non-opioid treatment ...

RICHLAND COUNTY, S.C. — A newly identified synthetic opioid known as Cychlorphine may be emerging in South Carolina, raising concerns among local officials and medical experts about its potency and ...